| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10060340 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10062373 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10060326 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
| TVIS10060442 | HBV | ENSG00000163631.19 | protein_coding | ALB | No | No | 213 | P02768 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ALB |
|---|---|
| DrugBank ID | DB00493 |
| Drug Name | Cefotaxime |
| Target ID | BE0000530 |
| UniProt ID | P02768 |
| Regulation Type | |
| PubMed IDs | 19164148 |
| Citations | Baneres-Roquet F, Gualtieri M, Villain-Guillot P, Pugniere M, Leonetti JP: Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions. Antimicrob Agents Chemother. 2009 Apr;53(4):1528-31. doi: 10.1128/AAC.00971-08. Epub 2009 Jan 21. |
| Groups | Approved |
| Direct Classification | Cephalosporin 3'-esters |
| SMILES | [H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)C1=CSC(N)=N1)C(O)=O |
| Pathways | |
| PharmGKB | PA448852 |
| ChEMBL | CHEMBL1730 |
